BioNTech kündigt strategische Partnerschaft mit der Regierung des Vereinigten Königreichs an, um bis 2030 bis zu 10.000 Patientinnen und Patienten mit personalisierten mRNA-Krebsimmuntherapien zu behandeln
05 janv. 2023 19h01 HE
|
BioNTech SE
Die mehrjährige Vereinbarung fokussiert sich auf drei strategische Bereiche: Krebsimmuntherapien, Impfstoffe gegen Infektionskrankheiten und weitere Expansion von BioNTech im Vereinigten...
BioNTech Announces Strategic Partnership with UK Government to Provide up to 10,000 Patients with Personalized mRNA Cancer Immunotherapies by 2030
05 janv. 2023 19h01 HE
|
BioNTech SE
Multi-year collaboration focuses on three strategic pillars: cancer immunotherapies, infectious disease vaccines, and expansion of BioNTech’s footprint in the UKBioNTech aims to design and roll out...
RxCelerate Acquires Methuselah Health and Launches ProQuant™ World-Beating Proteomics Service
22 nov. 2022 08h00 HE
|
RxCelerate
CAMBRIDGE, England, Nov. 22, 2022 (GLOBE NEWSWIRE) -- RxCelerate, a leading international out-sourced drug discovery and development platform, today announced the acquisition of drug discovery...
TILT Holdings’ Commonwealth Alternative Care Hosts Grand Opening at Newest Dispensary in Cambridge
16 sept. 2022 07h30 HE
|
TILT Holdings Inc.
PHOENIX, Sept. 16, 2022 (GLOBE NEWSWIRE) -- TILT Holdings Inc. (“TILT” or the “Company”) (NEO: TILT) (OTCQX: TLLTF), a global provider of cannabis business solutions that include inhalation...
TILT Holdings Receives Approval to Launch Medical Use Cannabis Operations at its Cambridge, Massachusetts Dispensary
30 août 2022 08h00 HE
|
TILT Holdings Inc.
PHOENIX, Aug. 30, 2022 (GLOBE NEWSWIRE) -- TILT Holdings Inc. (“TILT” or the “Company”) (NEO: TILT) (OTCQX: TLLTF), a global provider of cannabis business solutions that include inhalation...
Copia Scientific Announces the Acquisition of Atlantic Lab Equipment
04 août 2022 08h00 HE
|
Copia Scientific
TAUNTON, Mass., Aug. 04, 2022 (GLOBE NEWSWIRE) -- Copia Scientific, LLC, has acquired Atlantic Lab Equipment (originally formed in 2002). With the addition of Atlantic Lab Equipment, Copia has...
RxCelerate Launch RxNfinity™: A Next-Generation Machine Learning-Enabled Small Molecule Discovery Platform
19 juil. 2022 08h00 HE
|
RxCelerate
CAMBRIDGE, England, July 19, 2022 (GLOBE NEWSWIRE) -- RxCelerate, a leading international outsourced drug discovery and development platform, today revealed details of a new small molecule discovery...
Surface Oncology to Participate in the Oppenheimer Fall Healthcare Life Sciences & MedTech Summit
16 sept. 2020 17h05 HE
|
Surface Oncology, Inc.
CAMBRIDGE, Mass., Sept. 16, 2020 (GLOBE NEWSWIRE) -- Surface Oncology (Nasdaq: SURF), a clinical-stage immuno-oncology company developing next-generation immunotherapies that target the tumor...
Surface Oncology to Participate in the H.C. Wainwright Global Healthcare Conference
11 sept. 2020 15h00 HE
|
Surface Oncology, Inc.
CAMBRIDGE, Mass., Sept. 11, 2020 (GLOBE NEWSWIRE) -- Surface Oncology (Nasdaq:SURF), a clinical-stage immuno-oncology company developing next-generation immunotherapies that target the tumor...
Surface Oncology Reports Financial Results and Corporate Highlights for Second Quarter 2020
11 août 2020 06h30 HE
|
Surface Oncology, Inc.
CAMBRIDGE, Mass., Aug. 11, 2020 (GLOBE NEWSWIRE) -- Surface Oncology (Nasdaq: SURF), a clinical-stage immuno-oncology company developing next-generation immunotherapies that target the tumor...